Drug firms demand NPPA withdraw notices alleging overchargingPost published:August 30, 2017Post category:Industry NewsThe Indian Pharmaceutical Alliance has written to the pharma dept criticizing NPA for issuing demand notices to top drug makers over ‘suspected overcharging’ Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostSBI gears up for expected surge in affordable housing loan demand Next PostInfosys to start work on Kolkata centre: Mamata Banerjee You Might Also Like Boston Scientific may withdraw its high-end stent ‘Synergy’ from India September 20, 2017 OleumTech releases Tilt and Vibration Transmitters for the OTC Wireless Sensor & I/O Network May 30, 2019 HEMCO introduces ModuLab custom-designed room enclosure with control system August 2, 2019
OleumTech releases Tilt and Vibration Transmitters for the OTC Wireless Sensor & I/O Network May 30, 2019